drugbank_id,name,type,description,indication,atc_codes,categories
DB00001,Lepirudin,biotech,"Lepirudin is a recombinant hirudin formed by 65 amino acids that acts as a highly specific and direct thrombin inhibitor.[L41539,L41569] Natural hirudin is an endogenous anticoagulant found in _Hirudo medicinalis_ leeches.[L41539] Lepirudin is produced in yeast cells and is identical to natural hirudin except for the absence of sulfate on the tyrosine residue at position 63 and the substitution of leucine for isoleucine at position 1 (N-terminal end).[A246609] 

Lepirudin is used as an anticoa","Lepirudin is indicated for anticoagulation in adult patients with acute coronary syndromes (ACS) such as unstable angina and acute myocardial infarction without ST elevation. In patients with ACS, lepirudin is intended for use with [aspirin].[L41539] Lepirudin is also indicated for anticoagulation in patients with heparin-induced thrombocytopenia (HIT) and associated thromboembolic disease in order to prevent further thromboembolic complications.[L41539]",B01AE02,"Amino Acids, Peptides, and Proteins|Anticoagulants|Antithrombin Proteins|Antithrombins|Blood and Blood Forming Organs"
DB00002,Cetuximab,biotech,"Cetuximab is a recombinant chimeric human/mouse IgG1 monoclonal antibody that competitively binds to epidermal growth factor receptor (EGFR) and competitively inhibits the binding of epidermal growth factor (EGF).[A227973] EGFR is a member of the ErbB family of receptor tyrosine kinases found in both normal and tumour cells; it is responsible for regulating epithelial tissue development and homeostasis.[A228083] EGFR has been implicated in various types of cancer, as it is often overexpressed in","Cetuximab indicated for the treatment of locally or regionally advanced squamous cell carcinoma of the head and neck in combination with radiation therapy. It is indicated for treating a recurrent locoregional disease or metastatic squamous cell carcinoma of the head and neck in combination with platinum-based therapy with fluorouracil. It is indicated for recurrent or metastatic squamous cell carcinoma of the head and neck progressing after platinum-based therapy.[L30448]

Cetuximab is also i",L01FE01,"Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antineoplastic Agents"
DB00003,Dornase alfa,biotech,"Dornase alfa is a biosynthetic form of human deoxyribunuclease I (DNase I) enzyme. It is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. The 260-amino acid sequence of dornase alfa is identical to the endogenous human enzyme. Dornase alfa cleaves extracellular DNA to 5´-phosphodinucleotide and 5´-phosphooligonucleotide end products without affecting intracellular DNA. In individuals with cystic fibrosis, extracellular DNA, which is an extremel",Used as adjunct therapy in the treatment of cystic fibrosis. ,R05CB13,"Amino Acids, Peptides, and Proteins|Cough and Cold Preparations|Decreased Respiratory Secretion Viscosity|Deoxyribonucleases|Endodeoxyribonucleases"
DB00004,Denileukin diftitox,biotech,"Denileukin diftitox is an IL2-receptor-directed cytotoxin, is a recombinant DNA-derived fusion protein composed of the amino acid sequences for diphtheria toxin fragments A and B (Met<sub>1</sub>-Thr<sub>387</sub>)-His and the sequence for human interleukin-2 (IL-2; Ala<sub>1</sub>-Thr<sub>133</sub>).[L51254] It is designed to deliver diphtheria toxin into IL-2 receptor-expressing cancer cells to cause cell death.[A264349, L51254]

Denileukin diftitox was originally approved by the FDA in 1999",Denileukin diftitox was previously indicated for the treatment of adult patients with persistent or recurrent cutaneous T-cell lymphoma (CTCL) whose malignant cells express the CD25 component of the IL-2 receptor.[L26381] It is also indicated for the treatment of adult patients with relapsed or refractory Stage I-III CTCL after at least one prior systemic therapy.[L51254],L01XX29,"ADP Ribose Transferases|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Bacterial Toxins"
DB00005,Etanercept,biotech,"Dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.[L14862,A216522] The Fc component of etanercept contains the CH2 domain, the CH3 domain and hinge region, but not the CH1 domain of IgG1. Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It consists of 934 amino acids. It is used to treat or","Etanercept is indicated for the treatment of moderately to severely active rheumatoid arthritis in adults and in chronic moderate to severe plaque psoriasis in patients 4 years of age and older.[L14862,L45523] It is also used to manage signs and symptoms of polyarticular idiopathic arthritis and Juvenile Psoriatic Arthritis in those aged 2 years and older. Etanercept is also used to manage the symptoms of psoriatic arthritis and ankylosing spondylitis.[L48526] ",L04AB01,"Agents reducing cytokine levels|Amino Acids, Peptides, and Proteins|Anti-Inflammatory Agents|Antibodies|Antirheumatic Agents"
DB00006,Bivalirudin,small molecule,"Bivalirudin is a synthetic 20 residue peptide (thrombin inhibitor) which reversibly inhibits thrombin. Once bound to the active site, thrombin cannot activate fibrinogen into fibrin, the crucial step in the formation of thrombus. It is administered intravenously. Because it can cause blood stagnation, it is important to monitor changes in hematocrit, activated partial thromboplastin time, international normalized ratio and blood pressure.","For treatment of heparin-induced thrombocytopenia and for the prevention of thrombosis. Bivalirudin is indicated for use in patients undergoing percutaneous coronary intervention (PCI), in patients at moderate to high risk acute coronary syndromes due to unstable angina or non-ST segment elevation in whom a PCI is planned.",B01AE06,"Amino Acids, Peptides, and Proteins|Anticoagulants|Antithrombins|Blood and Blood Forming Organs|Enzyme Inhibitors"
DB00007,Leuprolide,biotech,"Leuprolide is a synthetic 9-residue peptide analogue of gonadotropin-releasing hormone (GnRH). Unlike the endogenous decapeptide GnRH, leuprolide contains a single D-amino acid (D-leucyl) residue, which helps to increase its circulating half-life from three to four minutes to approximately three hours.[A203222] As a GnRH mimic, leuprolide is capable of binding to the GnRH receptor (GnRHR) and inducing downstream modulation of both gonadotropin hormone and sex steroid levels. Prolonged activation","Leuprolide is indicated for the treatment of advanced prostate cancer [L13781, L34415] and as palliative treatment of advanced prostate cancer.[L13790] 

It is also used for the treatment of pediatric patients with central precocious puberty (CPP).[L13784, L13787] 

In combination with oral [norethisterone] (also known as norethindrone), leuprolide is also indicated for the initial treatment of the symptoms of endometriosis.[L10310] Finally, in combination with iron supplementation, leuproli",L02AE51|L02AE02,"Adrenal Cortex Hormones|Agents Causing Muscle Toxicity|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic Agents, Hormonal"
DB00008,Peginterferon alfa-2a,biotech,"Peginterferon alfa-2a is a form of recombinant interferon used as part of combination therapy to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV). HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States, and affecting 72% of all chronic HCV patients [L852]. Treatment options for chronic Hepatitis C have advanced significantly since 2011, with the developm","Peginterferon alfa-2a is indicated for the treatment of HCV in combination with other antiviral drugs in patients over 5 years of age with compensated liver disease [FDA Label]. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies.

Peginterferon alfa-2a is also indicated as a monotherapy for adult patients with HBeAg positive and HBeAg negative chronic hepatitis B infection who have compensated liver disease and evidence o",L03AB11|L03AB61,"Adjuvants, Immunologic|Alcohols|Alfa Interferons|Amino Acids, Peptides, and Proteins|Anti-Infective Agents"
DB00009,Alteplase,biotech,"Alteplase is a recombinant tissue plasminogen activator (rt-PA) used as a thrombolytic agent.[L43125] It cleaves plasminogen to form plasmin, an enzyme involved in the degradation of fibrin clots. In the absence of fibrin, the alteplase-mediated conversion of plasminogen is limited, thanks to the high affinity between alteplase and fibrin.[A252330,L43125] Alteplase is a purified glycoprotein of 527 amino acids expressed in Chinese hamster ovary (CHO) cells.[A252345,L43125] It was first approved ","Alteplase is indicated for the treatment of acute ischemic stroke (AIS) and for use in acute myocardial infarction (AMI) for the reduction of mortality and incidence of heart failure. Alteplase is also indicated for the lysis of acute massive pulmonary embolism, defined as acute pulmonary emboli obstructing blood flow to a lobe or multiple lung segments, and acute pulmonary emboli accompanied by unstable hemodynamics.[L43125]",B01AD02|S01XA13,"Agents causing angioedema|Amino Acids, Peptides, and Proteins|Anticoagulants|Blood and Blood Forming Organs|Blood Proteins"
DB00010,Sermorelin,biotech,Sermorelin acetate is the acetate salt of an amidated synthetic 29-amino acid peptide (GRF 1-29 NH 2 ) that corresponds to the amino-terminal segment of the naturally occurring human growth hormone-releasing hormone (GHRH or GRF) consisting of 44 amino acid residues,"For the treatment of dwarfism, prevention of HIV-induced weight loss",V04CD03|H01AC04,"Amino Acids, Peptides, and Proteins|Anterior Pituitary Lobe Hormones and Analogues|Diagnostic Agents|Growth Hormone-Releasing Hormone|Hormones"
DB00011,Interferon alfa-n1,biotech,"Interferon alfa-n1 consists of purified, natural (n is for natural) alpha interferon subtypes, at least two of which are glycosylated. This differs from recombinant alpha interferons, which are individual non-glycosylated proteins produced from individual alpha interferon genes.",For the treatment of venereal or genital warts caused by the Human Papiloma Virus.,L03AB06,"Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Antiviral Agents|Biological Factors"
DB00012,Darbepoetin alfa,biotech,"Human erythropoietin with 2 aa substitutions to enhance glycosylation (5 N-linked chains), 165 residues (MW=37 kD). Produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology.",For the treatment of anemia (from renal transplants or certain HIV treatment),B03XA02,"Amino Acids, Peptides, and Proteins|Antianemic Preparations|Blood and Blood Forming Organs|Carbohydrates|Colony-Stimulating Factors"
DB00013,Urokinase,biotech,"Urokinase is an endogenous peptide that is cleaved in the presence of plasmin between lysine 158 and isoleucine 159 to yield active urokinase.[A191943] Urokinase remains connected between these 2 chains by a sulfhydryl bond.[A191943]

Urokinase was granted FDA approval on 16 January 1978.[L12138]","In Canada, urokinase is indicated for lysis of acute massive pulmonary emboli, acute thrombi obstructing coronary arteries, occlusive thromboemboli in peripheral arteries and grafts, and restoration of patency to intravenous catheters.[L12141]",B01AD04,"Agents causing angioedema|Amino Acids, Peptides, and Proteins|Anticoagulants|Biological Factors|Blood and Blood Forming Organs"
DB00014,Goserelin,small molecule,"Goserelin is a synthetic hormone. In men, it stops the production of the hormone testosterone, which may stimulate the growth of cancer cells. In women, goserelin decreases the production of the hormone estradiol (which may stimulate the growth of cancer cells) to levels similar to a postmenopausal state. When the medication is stopped, hormone levels return to normal.","Goserelin is indicated for:

- Use in combination with flutamide for the management of locally confined carcinoma of the prostate
- Palliative treatment of advanced carcinoma of the prostate
- The management of endometriosis
- Use as an endometrial-thinning agent prior to endometrial ablation for dysfunctional uterine bleeding
- Use in the palliative treatment of advanced breast cancer in pre- and perimenopausal women",L02AE03,"Adrenal Cortex Hormones|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents"
DB00015,Reteplase,biotech,"Human tissue plasminogen activator, purified, glycosylated, 355 residues purified from CHO cells. Retavase is considered a ""third-generation"" thrombolytic agent, genetically engineered to retain and delete certain portions of human tPA. Retavase is a deletion mutein of human tPA formed by deleting various amino acids present in endogenous human tPA. Retavase contains 355 of the 527 amino acids of native human tPA (amino acids 1-3 and 176-527), and retains the activity-related kringle-2 and serin","For lysis of acute pulmonary emboli, intracoronary emboli, and management of myocardial infarction.",B01AD07,"Agents causing angioedema|Amino Acids, Peptides, and Proteins|Anticoagulants|Biological Factors|Blood and Blood Forming Organs"
DB00016,Erythropoietin,biotech,"Erythropoietin (EPO) is a growth factor produced in the kidneys that stimulates the production of red blood cells. It works by promoting the division and differentiation of committed erythroid progenitors in the bone marrow [FDA Label]. Epoetin alfa (Epoge) was developed by Amgen Inc. in 1983 as the first rhEPO commercialized in the United States, followed by other alfa and beta formulations. Epoetin alfa is a 165-amino acid erythropoiesis-stimulating glycoprotein produced in cell culture using ","Indicated in adult and paediatric patients for the: 

- treatment of anemia due to Chronic Kidney Disease (CKD) in patients on dialysis and not on dialysis.
- treatment of anemia due to zidovudine in patients with HIV-infection. 
- treatment of anemia due to the effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy.
- reduction of allogeneic RBC transfusions in patients undergoing elective, noncardiac, ",B03XA01,"Amino Acids, Peptides, and Proteins|Antianemic Preparations|Biological Factors|Blood and Blood Forming Organs|Carbohydrates"
DB00017,Salmon calcitonin,biotech,"Synthetic peptide, 32 residues long formulated as a nasal spray.","Used in the treatment of symptomatic Paget's disease for patients unresponsive to alternate treatments or intolerant to such treatments. In addition, it is used in emergency situations when serum calcium levels must be decreased quickly until the underlying condition is identified. It can also be added to existing therapeutic regimens for hypercalcemia such as intravenous fluids and furosemide, oral phosphate or corticosteroids, or other agents. Calcitonin can be used in patients with azotemia a",H05BA01,"Amino Acids, Peptides, and Proteins|Bone Density Conservation Agents|Bone Density, drug effects|Calcitonin Preparations|Calcium Homeostasis"
DB00018,Interferon alfa-n3,biotech,"Purified, natural (n is for natural) human interferon alpha proteins (consists of 3 forms or polymorphisms including 2a, 2b and 2c). 166 residues, some are glycosylated (MW range from 16 kD to 27 kD).",For the intralesional treatment of refractory or recurring external condylomata acuminata.,,"Alfa Interferons|Amino Acids, Peptides, and Proteins|Biological Factors|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)"
DB00019,Pegfilgrastim,biotech,"Pegfilgrastim is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue, [filgrastim].[A187601] The drug is approved for use to decrease the incidence of infection, as manifested by febrile neutropenia, in susceptible patients with with non-myeloid cancer receiving myelosuppressive anti-cancer treatment.[L9746] Although the risk of developing febrile neutropenia is less than 20% in many readily used chemotherapy regimens,[A248855] infections pose risks o","Pegfilgrastim is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non­ myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia.[L44221]

It is also indicated to increase survival in patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Subsyndrome of Acute Radiation Syndrome).[L44221]",L03AA13,"Adjuvants, Immunologic|Alcohols|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Biological Factors"
DB00020,Sargramostim,biotech,Sargramostim is a human recombinant granulocyte macrophage colony-stimulating factor (GM-CSF) expressed in yeast. It is a glycoprotein that is 127 residues. Substitution of Leu23 leads to a difference from native protein.,For the treatment of cancer and bone marrow transplant,L03AA09,"Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Biological Factors|Carbohydrates"
DB00022,Peginterferon alfa-2b,biotech,"Peginterferon alfa-2b is a form of recombinant interferon used as part of combination therapy to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV). HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States, and affecting 72% of all chronic HCV patients [L852]. Treatment options for chronic Hepatitis C have advanced significantly since 2011, with the developm","Peginterferon alfa-2b is indicated for the treatment of HCV in combination with [DB00811] and a NS3/4A protease inhibitor for genotype 1 or without a NS3/4A protease inhibitor for genotypes 2-6 [FDA Label]. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies.

It is also indicated for the adjuvant treatment of melanoma with microscopic or gross nodal involvement within 84 days of definitive surgical resection, including co",L03AB10|L03AB60,"Adjuvants, Immunologic|Alcohols|Alfa Interferons|Amino Acids, Peptides, and Proteins|Anti-Infective Agents"
DB00023,Asparaginase Escherichia coli,biotech,"Asparaginase derived from _Escherichia coli_ (L-asparagine amidohydrolase, EC 3.5.1.1) is an enzyme responsible for the metabolism of L-asparagine, by catalyzing L-asparagine into L-aspartic acid and ammonia. It also facilitates the production of oxaloacetate which is needed for general cellular metabolism. Asparaginase from _E. coli_ has clinically shown to exhibit antitumor actions in models of leukaemias [A31996, A31997]. L-asparaginase of _E. coli_ is marketed under several different trade n",Indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (ALL).[L39809],L01XX02,Amidohydrolases|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Asparaginase|Asparagine-specific Enzyme
DB00024,Thyrotropin alfa,biotech,"Thyrotropin alfa is a recombinant form of thyroid stimulating hormone used in performing certain tests in patients who have or have had thyroid cancer. It is also used along with a radioactive agent to destroy remaining thyroid tissue in certain patients who have had their thyroid gland removed because of thyroid cancer. It is a heterodimeric glycoprotein comprised of two non-covalently linked subunits, an alpha subunit of 92 amino acid residues containing two N-linked glycosylation sites and a ",For detection of residueal or recurrent thyroid cancer,H01AB01,"Agents used to treat hypothyroidism|Anterior Pituitary Lobe Hormones and Analogues|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptide Hormones"
DB00025,"Antihemophilic factor, human recombinant",biotech,"Human recombinant antihemophilic factor (AHF) or Factor VIII, 2332 residues, glycosylated, produced by CHO cells","The human recombinant antihemophilic factor is indicated for use in adults and children with hemophilia A for the control and prevention of bleeding episodes, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.[L41025, L36130]",B02BD02,"Amino Acids, Peptides, and Proteins|Biological Factors|Blood and Blood Forming Organs|Blood Coagulation Factors|Blood Proteins"
DB00026,Anakinra,biotech,"Anakinra is a recombinant human interleukin-1 (IL-1) receptor antagonist (IL-1Ra) composed of 153 amino acid residues. Unlike native human IL-1Ra, anakinra has an additional methionine residue at the amino terminus. This drug binds to the IL-1 receptor, competing with and inhibiting the activity of IL-1 alpha and beta.[L35415] Anakinra is indicated for the management of rheumatoid arthritis (RA) in patients 18 years of age or older who have failed one or more disease-modifying antirheumatic drug","Anakinra is an interleukin-1 receptor antagonist indicated for the reduction in signs and symptoms and slowing the progression of structural damage in moderately to severely active rheumatoid arthritis (RA), in patients 18 years of age or older who have failed one or more disease-modifying antirheumatic drugs (DMARDs). Anakinra can be used alone or in combination with DMARDs other than Tumor Necrosis Factor (TNF) blocking agents.[L35415]

Anakinra is also indicated for the treatment of Neonata",L04AC03,"Agents reducing cytokine levels|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Antirheumatic Agents|Biological Factors"
DB00027,Gramicidin D,small molecule,"Gramcidin D is a heterogeneous mixture of three antibiotic compounds, gramicidins A, B and C, making up 80%, 6%, and 14% respectively all of which are obtained from the soil bacterial species Bacillus brevis and called collectively gramicidin D. Gramcidins are 15 residue peptides with alternating D and L amino acids, which assemble inside of the hydrophobic interior of the cellular lipid bilayer to form a β-helix. Active against most Gram-positive bacteria and some Gram-negative organisms, Grami","For treatment of skin lesions, surface wounds and eye infections.",R02AB30,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Local|Membrane Proteins"
DB00028,Human immunoglobulin G,biotech,"Intravenous immunoglobulin (IVIg) is a mixture of IgG1 and other antibodies derived from healthy human plasma via Cohn fractionation. The purification process includes cold alcohol fractionation, polyethylene glycol precipitation, and ion exchange chromatography. IVIg contains the same distribution of IgG antibody subclasses as is found in the general human population. IgG subclasses are fully represented in the following proportions: 70.3% IgG1, 24.7% IgG2, 3.1% IgG3, and 1.9% IgG4. IVIg is use","Human immunoglobulin G is indicated for the following conditions:

### Primary Immunodeficiency
- for the treatment of primary immunodeficiency in adult and pediatric patients[L39920, L39930, L39935, L39940, L39945, L39950, L39955, L39960, L39965, L39975, L39980, L40029, L40034, L40044]
- in combination with [hyaluronidase (human recombinant)] for the treatment of primary immunodeficiency in patients ≥2 years of age.[L42760]

### Immune Thrombocytopenic Purpura (ITP)
- for the treatment o",,"Amino Acids, Peptides, and Proteins|Antibodies|Antigen Neutralization|Blood Proteins|Globulins"
DB00029,Anistreplase,biotech,"Human tissue plasminogen activator, purified, glycosylated, 527 residues purified from CHO cells. Eminase is a lyophilized (freeze-dried) formulation of anistreplase, the p-anisoyl derivative of the primary Lys-plasminogen-streptokinase activator complex (a complex of Lys-plasminogen and streptokinase). A p-anisoyl group is chemically conjugated to a complex of bacterial-derived streptokinase and human Plasma-derived Lys-plasminogen proteins.","For lysis of acute pulmonary emboli, intracoronary emboli and management of myocardial infarction",B01AD03,"Agents causing angioedema|Amino Acids, Peptides, and Proteins|Anticoagulants|Blood and Blood Forming Organs|Blood Proteins"
DB00030,Insulin human,biotech,"Human Insulin, also known as Regular Insulin, is a short-acting form of insulin used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes. Human insulin is produced by recombinant DNA technology and is identical to endogenously produced insulin. Typically prescribed for the management of diabetes mellitus, insulin is a peptide hormone produced by beta cells of the pancreas that promotes glucose metabolism. Insulin is released from the pancreas following a meal to promote the u",Human insulin is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.,A10AC01|A10AE01|A10AB01|A10AD01|A10AF01,"Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)"
DB00031,Tenecteplase,biotech,"Tenecteplase is a tissue plasminogen activator (tPA) developed from modifications of natural human tPA complementary DNA (cDNA). It is a 527 amino acid with a substitution of threonine 103 with asparagine and substitution of asparagine 117 with glutamine within the kringle 1 domain, and a tetra-alanine substitution at amino acids 296-299 in the protease domain.",For treatment of myocardial infarction and lysis of intracoronary emboli,B01AD11,"Agents causing angioedema|Amino Acids, Peptides, and Proteins|Anticoagulants|Biological Factors|Blood and Blood Forming Organs"
DB00032,Menotropins,biotech,"Menotropins contains follicle stimulating hormone (FSH) and luteinizing hormone (LH) purified from the urine of postmenopausal women.  It is used as a fertility medication that is injected either subcutaneously or intramuscularly. It is composed of LH with 2 subunits, alpha = 92 residues, beta = 121 residues and FSH with 2 subunits, alpha = 92 residues, beta=111 residues.",For the treatment of female infertility,G03GA02|G03GA03,"Amino Acids, Peptides, and Proteins|Biological Products|Complex Mixtures|Fertility Agents|Fertility Agents, Female"
DB00033,Interferon gamma-1b,biotech,"Human Interferon gamma-1b (140 residues), produced from E. coli. Production of Actimmune is achieved by fermentation of a genetically engineered Escherichia coli bacterium containing the DNA which encodes for the human protein. Purification of the product is achieved by conventional column chromatography. 
The sequence displayed is a cDNA sequence which codes for human interferon gamma, as described by Gray et. al. and not specifically interferon gamma 1b.",Interferon gamma-1b is used for the treatment of Chronic granulomatous disease and Osteopetrosis.,,"Amino Acids, Peptides, and Proteins|Biological Factors|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors"
DB00034,Interferon alfa-2a,biotech,Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.,"For the treatment of chronic hepatitis C, hairy cell leukemia, AIDS-related Kaposi's sarcoma, and chronic myelogenous leukemia. Also for the treatment of oral warts arising from HIV infection.",L03AB04,"Adjuvants, Immunologic|Alfa Interferons|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antineoplastic Agents"
DB00035,Desmopressin,small molecule,"Desmopressin (dDAVP), a synthetic analogue of 8-arginine vasopressin (ADH), is an antidiuretic peptide drug modified by deamination of 1-cysteine and substitution of 8-L-arginine by 8-D-arginine. ADH is an endogenous pituitary hormone that has a crucial role in the control of the water content in the body. Upon release from the stimulation of increased plasma osmolarity or decreased circulating blood volume, ADH mainly acts on the cells of the distal part of the nephron and the collecting tubule","- Indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void (intranasal). 

- Indicated as antidiuretic replacement therapy in the management of central cranial diabetes insipidus and for management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region (intranasal/parenteral).

- Indicated for patients with hemophilia A with factor VIII coagulant activity levels greater than 5% or mild",H01BA02,"Agents that produce hypertension|Amino Acids, Peptides, and Proteins|Antidiuretic Agents|Arginine Vasopressin|Cardiovascular Agents"
DB00036,Coagulation factor VIIa Recombinant Human,biotech,"Recombinant human coagulation Factor VIIa (rFVIIa), intended for promoting hemostasis by activating the extrinsic pathway of the coagulation cascade. NovoSeven is a vitamin K-dependent glycoprotein consisting of 406 amino acid residues. Cloned and expressed in hamster kidney cells, the protein is catalytically active in a two-chain form.",For treatment of hemorrhagic complications in hemophilia A and B.,B02BD08,"Amino Acids, Peptides, and Proteins|Biological Factors|Blood and Blood Forming Organs|Blood Coagulation Factors|Blood Proteins"
DB00038,Oprelvekin,biotech,"Oprelvekin, the active ingredient in Neumega®, is recombinant Interleukin-11 (IL-11), which is produced in Escherichia coli (E. coli) by recombinant DNA technology. With a molecular mass of approximately 19,000 daltons, the non-glycosylated protein is 177 amino acids in length in comparison to the natural IL-11, which is 178 amino acid long. However, it displays comparable biological activity compared to the natural IL-11 _in vitro_ and _in vivo_. Oprelvekin works by stimulating megakaryocytopoi",Indicated for the prevention of severe thrombocytopenia and the reduction of the need for platelet transfusions following myelosuppressive chemotherapy in adult patients with nonmyeloid malignancies who are at high risk of severe thrombocytopenia.[Label],L03AC02,"Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Biological Factors|Cytokines"
DB00039,Palifermin,biotech,"Palifermin is a recombinant human keratinocyte growth factor (KGF). It is 140 residues long, and is produced using E. coli.

Palifermin was granted FDA approval on 15 December 2004.[L17933]",For treatment of oral mucositis associated with chemotherapy and radiation therapy.,V03AF08,"Amino Acids, Peptides, and Proteins|Biological Factors|Detoxifying Agents for Antineoplastic Treatment|Fibroblast Growth Factors|Increased Epithelial Proliferation"
DB00040,Glucagon,biotech,"Glucagon is a 29 amino acid hormone used as a diagnostic aid in radiologic exams to temporarily inhibit the movement of the gastrointestinal tract and to treat severe hypoglycemia.[L7634,L7637,L7640,L7643,L8519] Glucagon raises blood sugar through activation of hepatic glucagon receptors, stimulating glycogenolysis and the release of glucose.[L7640,L7643]

Glucagon was granted FDA approval on 14 November 1960.[L7631]","Glucagon is indicated as a diagnostic aid in radiologic exams to temporarily inhibit the movement of the gastrointestinal tract and to treat severe hypoglycemia.[L7634,L7637,L7640,L7643,L8519]",H04AA01,"Amino Acids, Peptides, and Proteins|Antihypoglycemic Agent|Decreased GI Motility|Decreased GI Smooth Muscle Tone|Decreased Glycolysis"
DB00041,Aldesleukin,biotech,"Aldesleukin, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. Genetic engineering techniques were used to modify the human IL-2 gene, and the resulting expression clone encodes a modified human interleukin-2. This recombinant form differs from native interleukin-2 in the following ways: a) Aldesleukin is not glycosylated because it is derived from E. coli; b) the molecule has no N-terminal ",For treatment of adults with metastatic renal cell carcinoma.,L03AC01,"Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Anti-HIV Agents|Anti-Infective Agents|Antineoplastic Agents"
DB00042,Botulinum toxin type B,biotech,Neurotoxin produced by fermentation of clostridium botulinum type B. The protein exists in noncovalent association with hemagglutinin and nonhemagglutinin proteins as a neurotoxin complex. The neurotoxin complex is recovered from the fermentation process and purified through a series of precipitation and chromatography steps.,For the treatment of patients with cervical dystonia to reduce the severity of abnormal head position and neck pain associated with cervical dystonia.,M03AX01,"Acetylcholine Release Inhibitors|Agents that produce neuromuscular block (indirect)|Amino Acids, Peptides, and Proteins|Amphibian Venoms|Anti-Dyskinesia Agents"
DB00043,Omalizumab,biotech,"Omalizumab is a recombinant DNA-derived humanized monoclonal antibody directed against human immunoglobulin E (IgE).[L50482] IgE promotes the release of inflammatory mediators from mast cells and basophils during allergic and inflammatory reactions. By binding to IgE and neutralizing it, omalizumab reduces free IgE levels and prevents IgE from binding to its receptors on immune cells.[A39518]

Omalizumab was first approved in the US in 2003 [A263507] and in Europe in 2005.[L50482] It is used t","Omalizumab is indicated for:
- the treatment of patients six years of age and older with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids.[L50477, L50482]
- add-on maintenance treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) in adults with inadequate response to nasal corticosteroids.[L50477, L50482]
- the reduction of allergic reaction",R03DX05,"Agents to Treat Airway Disease|Amino Acids, Peptides, and Proteins|Anti-Allergic Agents|Anti-Asthmatic Agents|Anti-IgE"
DB00044,Lutropin alfa,biotech,"Lutropin alfa is a recombinant human luteinizing hormone produced in yeast with 2 subunits, alpha = 92 residues, beta = 121 residues. It is a heterodimeric glycoprotein made up of monomeric units. Lutropin alfa was the first and only recombinant human form of luteinizing hormone (LH) developed for use in the stimulation of follicular development. Its pharmacological action mimics the biological activity of endogenous LH; an acute rise of LH, or LH surge, in females triggers ovulation and the dev",For treatment of infertility in women with hypothalamic or pituitary insufficiency (hypogonadotropic hypogonadism) and profound LH deficiency (LH <1.2 international units [IU]/L),G03GA07,Genito Urinary System and Sex Hormones|Gonadotropins|Gonadotropins and Antigonadotropins|Sex Hormones and Modulators of the Genital System
DB00045,Lyme disease vaccine (recombinant OspA),biotech,"Vaccine against Lyme disease that contains lipoprotein OspA, an outer surface protein of Borrelia burgdorferi sensu stricto ZS7, as expressed by Escherichia coli. Lipoprotein OspA is a single polypeptide chain of 257 amino acids with lipids covalently bonded to the N terminus. It is conjugated with alum (aluminum hydroxide) as an adjuvant.",For prophylactic treatment of Lyme Disease,,
DB00046,Insulin lispro,biotech,"Insulin lispro is a rapid-acting form of insulin used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes. Insulin is prescribed for the management of diabetes mellitus to mimic the activity of endogenously produced human insulin, a peptide hormone produced by beta cells of the pancreas that promotes glucose metabolism. Insulin is released from the pancreas following a meal to promote the uptake of glucose from the blood into internal organs and tissues such as the liver, fat",Insulin lispro is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.[L47616],A10AC04|A10AB04|A10AD04,"Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)"
DB00047,Insulin glargine,biotech,"Insulin glargine is a long-acting form of insulin used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes. Insulin is typically prescribed for the management of diabetes mellitus to mimic the activity of endogenously produced human insulin, a peptide hormone produced by beta cells of the pancreas that promotes glucose metabolism. Insulin is released from the pancreas following a meal to promote the uptake of glucose from the blood into internal organs and tissues such as the","Insulin glargine is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.[L12474,L43532,L43587]",A10AE54|A10AE04,"Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Antimetabolites|Biological Products|Blood Glucose Lowering Agents"
DB00048,Collagenase clostridium histolyticum,biotech,"Collagenase clostridium histolyticum is an enzyme produced by the bacterium Clostridium histolyticum. It is beneficial in the breakdown of collagen plaques for the treatment of Dupuytren's contracture and Peyronie's disease.[L14882] The topical formulation is used for the debridement of necrotic tissue due to burns or chronic ulcers.[L14912]

On July 6, 2020 a combination of injectable bacterial collagenases was approved by the FDA for the treatment of cellulite in adult women.[L14872] Also kn","Collagenase clostridium histolyticum is indicated for the treatment of adults with Dupuytren's contracture with a palpable cord. Additionally, it is used to treat men with Peyronie's disease diagnosed with a penile curvature deformity of at least a 30-degree angle at the beginning of therapy in addition to palpable plaques.[L14882] Collagenase ointment is used for the tissue debridement of chronic dermal ulcers and severely burned tissues.[L14952]
The combination collagenase product, also known",D03BA02|M09AB02|D03BA52,Collagen-specific Enzyme|Collagenases|Dermatologicals|Endopeptidases|Enzymes
DB00049,Rasburicase,biotech,Rasburicase is a recombinant urate-oxidase enzyme produced by a genetically modified <i>Saccharomyces cerevisiae</i> strain. The cDNA coding for rasburicase was cloned from a strain of _Aspergillus flavus_.,"For treatment of hyperuricemia, reduces elevated plasma uric acid levels (from chemotherapy)",V03AF07|M04AX01,Antigout Preparations|Detoxifying Agents for Antineoplastic Treatment|Enzymes|Enzymes and Coenzymes|Methemoglobinemia Associated Agents
DB00050,Cetrorelix,small molecule,"Cetrorelix is a man-made hormone that blocks the effects of Gonadotropin Releasing Hormone (GnRH). GnRH controls another hormone that is called luteinizing hormone (LH), which is the hormone that starts ovulation during the menstrual cycle. When undergoing hormone treatment sometimes premature ovulation can occur, leading to eggs that are not ready for fertilization to be released. Cetrorelix does not allow the premature release of these eggs to occur.",For the inhibition of premature LH surges in women undergoing controlled ovarian stimulation,H01CC02,"Amino Acids, Peptides, and Proteins|Anti-Gonadotropin-Releasing Hormones|Decreased GnRH Secretion|Fertility Agents|Fertility Agents, Female"
DB00051,Adalimumab,biotech,"Adalimumab is a subcutaneously administered biological disease modifier for the treatment of rheumatoid arthritis and other chronic debilitating diseases mediated by tumor necrosis factor.[A39984,A39999] It was originally launched by Abbvie in the U.S. and approved in 2002 by the FDA.[A39983] This drug is frequently known as _Humira_. It is produced by recombinant DNA technology using a mammalian cell expression system. This drug is available in a prefilled syringe form and convenient pen form f","Adalimumab is indicated for the following conditions:[L49101]

- Moderately to severely active Rheumatoid Arthritis (RA) in adults, as monotherapy or in combination with [methotrexate] or other non-biologic disease-modifying anti-rheumatic drugs (DMARDs).[L42290, L42495, L42935, L44953, L45643, L45818, L49101]
- Moderately to severely active polyarticular Juvenile Idiopathic Arthritis (JIA) in patients two years of age and older, as monotherapy or in combination with [methotrexate].[L42290, L",L04AB04,"Agents reducing cytokine levels|Amino Acids, Peptides, and Proteins|Anti-Inflammatory Agents|Antibodies|Antibodies, Monoclonal"
DB00052,Somatotropin,biotech,"Human growth hormone (HGH), also known as somatotropin, is a peptide hormone that is synthesized and secreted by the somatotropic cells of the anterior pituitary gland.[A228183] Growth hormone plays an essential role in growth regulation during childhood as well as other basal metabolic functions, muscle and fat mass regulation, blood glucose level regulation, and lipid regulation in both children and adults.[A228183, L31508] Synthesized in a strain of _Escherichia coli_, recombinant HGH is a po","Somatotropin is indicated for the treatment of pediatric patients who have growth failure due to an inadequate secretion of endogenous growth hormone, short stature associated with Turner syndrome, Prader-Willi syndrome (PWS), idiopathic short stature (ISS), short stature or growth failure in short stature homeobox-containing gene (SHOX) deficiency, and short stature born small for gestational age (SGA).[L31513, L31518] It is indicated for the treatment of growth failure in children associated w",H01AC01,"Agents Causing Muscle Toxicity|Amino Acids, Peptides, and Proteins|Anterior Pituitary Lobe Hormones and Analogues|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)"
DB00053,Imiglucerase,biotech,"Human Beta-glucocerebrosidase or Beta-D-glucosyl-N-acylsphingosine glucohydrolase E.C. 3.2.1.45. 497 residue protein with N-linked carbohydrates, MW=59.3 kD. Alglucerase is prepared by modification of the oligosaccharide chains of human Beta-glucocerebrosidase. The modification alters the sugar residues at the non-reducing ends of the oligosaccharide chains of the glycoprotein so that they are predominantly terminated with mannose residues.",For the treatment of Gaucher's disease (deficiency in glucocerebrosidase),A16AB02,Alimentary Tract and Metabolism|Enzyme Replacement Therapy|Enzymes|Enzymes and Coenzymes|Gaucher Disease
DB00054,Abciximab,biotech,"Abciximab is a Fab fragment of the chimeric human-murine monoclonal antibody 7E3. Abciximab binds to the glycoprotein (GP) IIb/IIIa receptor of human platelets and inhibits platelet aggregation by preventing the binding of fibrinogen, von Willebrand factor, and other adhesive molecules. It also binds to vitronectin (αvβ3) receptor found on platelets and vessel wall endothelial and smooth muscle cells.",Abciximab is indicated as an adjunct to percutaneous coronary intervention for the prevention of cardiac ischemic complications in patients undergoing percutaneous coronary intervention and in patients with unstable angina not responding to conventional medical therapy when percutaneous coronary intervention is planned within 24 hours. Abciximab is intended for use with aspirin and heparin and has been studied only in that setting.,B01AC13,"Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Anticoagulants"
DB00055,Drotrecogin alfa,biotech,"Drotrecogin alfa is activated human protein C that is synthesized by recombinant DNA technology. It is a glycoprotein of approximately 55 kilodalton molecular weight, consisting of a heavy chain and a light chain linked by a disulfide bond. Drotrecogin alfa was withdrawn from the market after a major study indicated that it was not effective in improving outcomes in patients with sepsis.",For reduction of mortality in patients with severe sepsis.,B01AD10,"Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Anticoagulants|Biological Factors|Blood and Blood Forming Organs"
DB00056,Gemtuzumab ozogamicin,biotech,"Gemtuzumab ozogamicin is a recombinant humanized IgG4 kappa antibody which is conjugated with calicheamicin derivative, a cytotoxic antitumor antibiotic isolated from fermentation of Micromonospora echinospora ssp. calichensis. Gemtuzumab ozogamicin has approximately 50% of the antibody loaded with 4-6 moles calicheamicin per mole of antibody [FDA Label]. The antibody is specifically directed against the CD33 antigen present on leukemic myeloblasts in most patients with acute myeloid leukemia (A",Indicated for the treatment of patients with CD33 positive acute myeloid leukemia in first relapse who are 60 years of age or older and who are not considered candidates for other cytotoxic chemotherapy. Indicated for the treatment of patients aged 2 years and older with CD33-positive AML who have experienced a relapse or who have not responded to initial treatment (refractory). ,L01FX02,"Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antibody-drug Conjugates"
DB00057,Indium In-111 satumomab pendetide,biotech,Tumor associated glycoprotein (TAG) 72 (B72.3) monoclonal antibody conjugated with Indium 111 for radioimaging colon tumors. Satumomab Pendetide (trade name: OncoScint®) is no longer commercially available.,For diagnosis of extrahepatic malignant cancers,V09IB02,"Acetates|Acids, Acyclic|Amines|Amino Acids, Peptides, and Proteins|Antibodies"
DB00058,Alpha-1-proteinase inhibitor,biotech,"Human alpha-1 proteinase inhibitor or alpha-1-antitrypsin, prepared from human plasma via Cohn alcohol fractionation followed by PEG and zinc chloride fractionation.",For chronic augmentation and maintenance therapy in individuals with alpha1-proteinase inhibitor (A1-PI) deficiency and clinical evidence of emphysema.,B02AB02,"Acute-Phase Proteins|Alpha-Globulins|Amino Acids, Peptides, and Proteins|Antifibrinolytic Agents|Blood and Blood Forming Organs"
DB00059,Pegaspargase,biotech,"Pegaspargase is a conjugate of monomethoxypolyethylene glycol (mPEG) and L-asparaginase (L-asparagine amidohydrolase), an asparagine-specific enzyme that converts L-asparagine into aspartic acid and ammonia.[L44667] Asparagine is an amino acid that is vital for cell survival. In humans, most normal tissues can produce asparagine through the action of asparagine synthetase. However, leukemia cells have low levels of this enzyme and depend on exogenous sources. Therefore, the use of pegaspargase r",Pegaspargase is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of pediatric and adult patients with 1) first-line acute lymphoblastic leukemia or 2) acute lymphoblastic leukemia and hypersensitivity to asparaginase.[L44667],L01XX24,Alcohols|Amidohydrolases|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Asparaginase
DB00060,Interferon beta-1a,biotech,"Human interferon beta (166 residues), glycosylated, MW=22.5kD. It is produced by mammalian cells (Chinese Hamster Ovary cells) into which the human interferon beta gene has been introduced. The amino acid sequence is identical to that of natural human interferon beta.","For treatment of relapsing/remitting multiple sclerosis, also for condyloma acuminatum",L03AB07,"Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antineoplastic and Immunomodulating Agents|Antiviral Agents"
DB00061,Pegademase,biotech,Bovine adenosine deaminase derived from bovine intestine that has been extensively pegylated for extended serum half life.,For treatment of adenosine deaminase deficiency,L03AX04,"Adjuvants, Immunologic|Aminohydrolases|Antineoplastic and Immunomodulating Agents|Bovine Intestinal Adenosine Deaminase|Enzymes"
DB00062,Albumin human,biotech,"Human serum albumin is the primary protein present in human blood plasma. The main function of albumin is to maintain the oncotic pressure of blood [A33706]. It binds to water, cations (such as Ca2+, Na+ and K+), fatty acids, hormones, bilirubin, thyroxine (T4) and pharmaceuticals (including barbiturates).  Albumin represents approximately 50% of the total protein content in healthy humans [A40060].

Human albumin is a small globular protein (molecular weight: 66.5 kDa), consisting of a single","Albuminex solution is indicated for adults and children for hypovolemia, ascites, hypoalbuminemia including from burns, acute nephrosis, acute respiratory distress syndrome and cardipulmonary bypass [F229].",B05AA01,"Albumins|Amino Acids, Peptides, and Proteins|Blood and Blood Forming Organs|Blood and Related Products|Blood Derivatives"
DB00063,Eptifibatide,biotech,"Synthetic cyclic hexapeptide that binds to platelet receptor glycoprotein and inhibits platelet aggregation. Derived from venom of the Southeastern pygmy rattlesnake (Sistrurus miliarus barbouri), eptifibatide is a cyclic heptapeptide that belongs to the class of arginin-glycin-aspartat-mimetics.",For treatment of myocardial infarction and acute coronary syndrome.,B01AC16,"Amino Acids, Peptides, and Proteins|Antiplatelet agents|Blood and Blood Forming Organs|Decreased Platelet Aggregation|Hematologic Agents"
DB00065,Infliximab,biotech,Infliximab is a tumor necrosis factor (TNF-alpha or TNF-α) blocker and a chimeric monoclonal IgG1 antibody composed of human constant (75%) and murine variable (25%) regions [A31469]. Infliximab is produced by a recombinant cell line cultured by continuous perfusion. Tumor necrosis factor-alpha (TNF-α) is a key proinflammatory cytokine involved in chronic inflammatory diseases [A31469]. Its hyperactivity and enhanced signalling pathways can be observed in inflammatory diseases where it activates,"Infliximab is indicated for the following conditions: 

- moderately to severely active ulcerative colitis following treatment with an infliximab product administered intravenously  [L51793]
- moderately to severely active Crohn’s disease following treatment with an infliximab product administered intravenously [L51793]
- 


use in combination with methotrexate for the reduction in signs and symptoms, inhibition of
the progression of structural damage and improvement in physical function",L04AB02,"Agents Causing Muscle Toxicity|Agents reducing cytokine levels|Amino Acids, Peptides, and Proteins|Anti-Inflammatory Agents|Antibodies"
DB00066,Follitropin,biotech,"Follitropin is a human follicle stimulating hormone (FSH) preparation of recombinant DNA origin, which consists of two non-covalently linked, non-identical glycoproteins designated as the alpha- and beta- subunits. The alpha- and beta- subunits have 92 and 111 amino acids. The alpha subunit is glycosylated at Asn 51 and Asn 78 while the beta subunit is glycosylated at Asn 7 and Asn 24. Follitropin beta is produced in genetically engineered Chinese hamster cell lines (CHO). The nomenclature “beta","In women having been diagnosed with primary ovarian failure, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. In men with hypogonadotrophic hypogonadism, it is used to induce spermatogenesis. Follitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use in gamete intrafallopian transfer (GIFT) or in vitro fertilization (IVF).",G03GA06|G03GA10|G03GA05,"Amino Acids, Peptides, and Proteins|Follicle Stimulating Hormone|Genito Urinary System and Sex Hormones|Gonadotropins|Gonadotropins and Antigonadotropins"
DB00067,Vasopressin,biotech,"Vasopressin (arginine-vasopressin or antidiuretic hormone) is a nonapeptide primarily produced in the hypothalamus that exhibits diverse physiological functions related to diuresis, hemodynamic modulation, and behaviour.[A110, A111, A112, A113, A228008] Vasopressin is very similar to oxytocin, differing in the third and eighth amino acids.[A228013] Despite a wide variety of functions, exogenous vasopressin is primarily used to control blood pressure during systemic shock by increasing vasoconstr",Vasopressin is indicated to increase blood pressure in adults in vasodilatory shock refractory to the application of fluids and catecholamines.[L31413],,"Amino Acids, Peptides, and Proteins|Antidiuretic Agents|Arginine Vasopressin|Arginine Vasopressin, analogs & derivatives|Cardiovascular Agents"
DB00068,Interferon beta-1b,biotech,"Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD",Interferon beta-1b is a drug used for the treatment of relapsing/remitting multiple sclerosis. It has been shown to slow the advance of the disease as well as to decrease the frequency of attacks.,L03AB08,"Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Biological Factors|Cytochrome P-450 CYP1A2 Inhibitors"
DB00069,Interferon alfacon-1,biotech,"Interferon alfacon-1 is a recombinant non-naturally occurring type-I interferon. The 166-amino acid sequence of Interferon alfacon-1 was derived by scanning the sequences of several natural interferon alpha subtypes and assigning the most frequently observed amino acid in each corresponding position. Four additional amino acid changes were made to facilitate the molecular construction, and a corresponding synthetic DNA sequence was constructed using chemical synthesis methodology. Interferon alf","For the treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma",L03AB09,"Adjuvants, Immunologic|Alfa Interferons|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antineoplastic and Immunomodulating Agents"
DB00070,Hyaluronidase (ovine),biotech,Highly purified sheep hyaluronidase for administration by injection into the vitreous of the eye.,For increase of absorption and distribution of other injected drugs and for rehydration.,,Enzymes|Enzymes and Coenzymes|Glycoside Hydrolases
DB00071,Insulin pork,biotech,"Insulin isolated from pig pancreas. Composed of alpha and beta chains, processed from pro-insulin. Forms a hexameric structure.",For the treatment of type I and II diabetes mellitus.,A10AC03|A10AB03|A10AE03|A10AD03,"Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)"
DB00072,Trastuzumab,biotech,"Produced in CHO cell cultures, trastuzumab is a recombinant IgG1 kappa, humanized monoclonal antibody [A40276] that selectively binds with high affinity in a cell-based assay (Kd = 5 nM) to the extracellular domain of the human epidermal growth factor receptor protein (HER2).[L14015] It is used as a treatment of human epidermal growth factor receptor (HER)-2+ metastatic breast cancer, where there is a proven amplification of the HER-2 oncogene or over-expression of the HER-2 protein in tumours. ","For the adjuvant treatment of HER2-overexpressing breast cancer, trastuzumab is indicated in several clinical settings: as part of a treatment regimen consisting of doxorubicin, cyclophosphamide, and either paclitaxel or docetaxel; as part of a treatment regimen with docetaxel and carboplatin; or as monotherapy following multi-modality anthracycline-based therapy.[L14015]

Trastuzumab is indicated as a first-line treatment, in combination with paclitaxel, for metastatic HER2-overexpressing bre",L01FD01|L01FY01,"Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antineoplastic Agents"
DB00073,Rituximab,biotech,"Rituximab is a genetically engineered chimeric murine/human monoclonal antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes. The antibody is an IgG1 kappa immunoglobulin containing murine light and heavy-chain variable region sequences and human constant region sequences [A40017], [FDA label]. It was originally approved by the U.S. FDA in 1997 as a single agent to treat patients with B-cell Non-Hodgkin's Lymphoma (NHL) [L4811], however, has now be","Rituximab is indicated for the treatment of adult patients with relapsed or refractory, low-grade or follicular, CD20-positive, B-cell non-Hodgkin’s Lymphoma (NHL) as a single agent. Also, it is indicated for the treatment of adult patients with previously untreated follicular, CD20-positive, B-cell NHL in combination with first line chemotherapy and, in patients achieving a complete or partial response to a rituximab product in combination with chemotherapy, as single-agent maintenance therapy.",L01FA01,"Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Murine-Derived|Antineoplastic Agents"
DB00074,Basiliximab,biotech,"A recombinant chimeric (murine/human) monoclonal antibody (IgG1k) that functions as an immunosuppressive agent, specifically binding to and blocking the interleukin-2 receptor a-chain (IL-2R alpha, also known as CD25 antigen) on the surface of activated T-lymphocytes. It is a 144 kDa glycoprotein obtained from fermentation of an established mouse myeloma cell line genetically engineered to express plasmids containing the human heavy and light chain constant region genes and mouse heavy and light",For prophylactic treatment of kidney transplant rejection,L04AC02,"Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antineoplastic and Immunomodulating Agents"
DB00075,Muromonab,biotech,"Murine monoclonal antibody specific to CD3 T-cell lymphocyte antigens. More specifically it is a purified murine (mouse) monoclonal antibody, directed against the CD3 (T3) receptor on the surface of human T-cells (T-lymphocytes) cultured using the murine ascites method. Muromonab is 93% monomeric immune globulin G type 2a (IgG2a).","For treatment of organ transplant recipients, prevention of organ rejection",L04AG01,"Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Murine-Derived|Antineoplastic and Immunomodulating Agents"
DB00076,Digoxin Immune Fab (Ovine),biotech,Digoxin Immune Fab is a sheep antibody (26-10) FAB fragment from sheep immunized with the digoxin derivative Digoxindicarboxymethylamine. It is used as an antidote for overdose of digoxin.,For treatment of digitoxin overdose or digitalis glycoside toxicity.,V03AB24,"Amino Acids, Peptides, and Proteins|Antidotes|Blood Proteins|Digoxin Binding Activity|Immunoglobulin G"
DB00078,Ibritumomab tiuxetan,biotech,"Indium or yttrium conjugated murine IgG1 kappa monoclonal antibody directed against the CD20 antigen, which is found on the surface of normal and malignant B lymphocytes. Ibritumomab is produced in Chinese hamster ovary cells and is composed of two murine gamma 1 heavy chains of 445 amino acids each and two kappa light chains of 213 amino acids each.",For treatment of non-Hodgkin's lymphoma,V10XX02,"Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antigens, CD20|Blood Proteins"
DB00080,Daptomycin,small molecule,"Daptomycin is a cyclic lipopeptide antibacterial agent with a broad spectrum of activity against Gram-positive bacteria, including methicillin-susceptible and -resistant _Staphylococcus aureus_ (MSSA/MRSA) and vancomycin-resistant Enterococci (VRE).[A231379, A231384, L32534] Chemically, daptomycin comprises 13 amino acids, including several non-standard and D-amino acids, with the C-terminal 10 amino acids forming an ester-linked ring and the N-terminal tryptophan covalently bonded to decanoic a","Daptomycin is indicated for the treatment of complicated skin and skin structure infections (cSSSI) in patients one year of age and older. It is also indicated for the treatment of _Staphylococcus aureus_ bloodstream infections (bacteremia) in patients one year of age and older, including in adult patients with right-sided infective endocarditis.[L32534]

Daptomycin is not indicated for the treatment of pneumonia or left-sided infective endocarditis due to _S. aureus_. Use is not recommended i",J01XX09,"Agents Causing Muscle Toxicity|Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use"
DB00081,Tositumomab,biotech,"Murine IgG2a lambda monoclonal antibody against CD20 antigen (2 heavy chains of 451 residues, 2 lambda chains of 220 residues). It is produced in an antibiotic-free culture of mammalian cells. It can be covalently linked to Iodine 131 (a radioactive isotope of iodine).","For treatment of non-Hodgkin's lymphoma (CD20 positive, follicular)",V10XA53,"Amino Acids, Peptides, and Proteins|Antibodies|Antigens, CD20|Antineoplastic Agents|Blood Proteins"
DB00082,Pegvisomant,biotech,"Pegvisomant is a highly selective growth hormone (GH) receptor antagonist. It is used to treat acromegaly.  Unlike dopamine or somatostatin analogs (which inhibit growth hormone secretion), this drug actually blocks the hepatic (GH-mediated) production of insulin like growth factor (IGF-1), which is the main mediator of growth hormone activity.",Pegvisomant is a growth hormone receptor antagonist used for the treatment of acromegaly.,H01AX01,"Acromegaly|Amino Acids, Peptides, and Proteins|Anterior Pituitary Lobe Hormones and Analogues|Cholinesterase Inhibitors|Cytochrome P-450 CYP3A Inducers"
DB00083,Botulinum toxin type A,biotech,"In 2002, botulinum toxin A, also known as onabotulinumtoxinA or Botox, was the first type A botulism toxin to be introduced into the market for cosmetic use.[A231824] With a wide variety of applications and favourable safety profile, Botulinum toxin A injection is a minimally invasive and promising treatment for cosmetic imperfections, muscle spasms, and other conditions.[A231819,L32569] A popular use for Botox is the treatment of facial wrinkles and lines, however, there are many uses for the b","Botulinum toxin A is indicated for a variety of conditions, depending on the preparations. Cosmetically, it is used for the treatment of facial fine lines and wrinkles, specifically for upper facial rhytides, including forehead, lateral canthus, and glabellar lines.[L32559]

In addition to the above indications, botulinum toxin A is used for the following conditions: treatment of adults with symptomatic overactive bladder with or without incontinence,  treatment of incontinence in adult patien",M03AX01,"Acetylcholine Release Inhibitors|Agents that produce neuromuscular block (indirect)|Amino Acids, Peptides, and Proteins|Bacterial Proteins|Bacterial Toxins"
DB00085,Pancrelipase,biotech,"Pancrelipase, in general, is composed of a mixture of pancreatic enzymes which include amylases, lipases, and proteases. These enzymes are extracted from porcine pancreatic glands.[L2509] The pancrelipase mixture was developed by Ortho-McNeil-Janssen Pharmaceuticals, Inc and FDA approved on April 12, 2010.[L2510] For further information on the components of this mixture please visit [DB11065], [DB11066] and [DB13147].","The use of pancrelipase amylase is part of the pancreatic enzyme replacement therapy. This therapy is indicated for the treatment of pancreatic insufficiency attributed to cystic fibrosis, chronic pancreatitis or any other medically defined pancreatic disease that might require it.[A32721, A32736] Pancreatic diseases are associated with the deterioration of pancreatic parenchyma and of the dual physiological functions of the pancreas. Once established, pancreatic insufficiency results in malnutr",A09AA02,"Alimentary Tract and Metabolism|Carboxylic Ester Hydrolases|Complex Mixtures|Digestives, Incl. Enzymes|Enzyme Preparations"
DB00086,Streptokinase,biotech,"Streptokinase, is a sterile, purified preparation of a bacterial protein elaborated by group C (beta) -hemolytic streptococci.","For the treatment of acute evolving transmural myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis or emolism and occlusion of arteriovenous cannulae",B01AD01|B06AA55,"Agents causing angioedema|Amino Acids, Peptides, and Proteins|Anticoagulants|Blood and Blood Forming Organs|Blood Proteins"
DB00087,Alemtuzumab,biotech,"Alemtuzumab is a humanized monoclonal antibody specific to lymphocyte antigens. It is a recombinant DNA-derived humanized monoclonal antibody (Campath-1H) that is directed against the 21-28 kD cell surface glycoprotein, CD52. The Campath-1H antibody is an IgG1 kappa with the human variable framework and constant regions, and complementarity-determining regions from a murine (rat) monoclonal antibody (Campath-1G). Alemtuzumab is produced in mammalian cell (Chinese hamster ovary) suspension cultur","LEMTRADA is indicated for the treatment of relapsing forms of multiple sclerosis (MS), including relapsing-remitting disease and active secondary progressive disease, in adults. Because of its safety profile, the use of LEMTRADA should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS.[L43397] LEMTRADA contains the same active ingredient (alemtuzumab) found in CAMPATH, and CAMPATH is approved for the treatment of B-cell ",L04AG06,"Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antineoplastic Agents"
DB00088,Alglucerase,biotech,"Human Beta-glucocerebrosidase or Beta-D-glucosyl-N-acylsphingosine glucohydrolase E.C. 3.2.1.45. 497 residue protein with N-linked carbohydrates, MW=59.3 kD. Alglucerase is prepared by modification of the oligosaccharide chains of human Beta-glucocerebrosidase. The modification alters the sugar residues at the non-reducing ends of the oligosaccharide chains of the glycoprotein so that they are predominantly terminated with mannose residues. Alglucerase was first approved by the FDA in 1991;[A254","Alglucerase is indicated for use as a long-term enzyme replacement therapy in patients with Type I Gaucher disease who exhibit signs and symptoms that are severe enough to result in moderate-to-severe anemia, thrombocytopenia, bone disease, or significant hepato- or splenomegaly.[L44266]",A16AB01,Alimentary Tract and Metabolism|Enzyme Replacement Therapy|Enzymes|Enzymes and Coenzymes|Gaucher Disease
DB00089,Capromab pendetide,biotech,"Capromab is a Murine IgG1 monoclonal 7E11-C5.3 antibody that recognizes prostate specific membrane antigen (PSMA – also known as glutamate carboxypeptidase 2) from prostate cancer cells and normal prostate tissue. When linked to pendetide, capromab is used as a chelating agent for the radionuclide [Indium In-111] during imaging to evaluate the extent of prostate cancer.",For diagnosis of prostate cancer and detection of intra-pelvic metastases.,V09IB04,"Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Compounds used in a research, industrial, or household setting|Diagnostic Radiopharmaceuticals"
DB00090,Laronidase,biotech,"Human recombinant alpha-L-iduronidase, 628 residues (mature form), produced by recombinant DNAtechnology in a Chinese hamster ovary cell line. Laronidase is a glycoprotein with a molecular weight of approximately 83 kD. The predicted amino acid sequence of the recombinant form, as well as the nucleotide sequence that encodes it, are identical to a polymorphic form of human a-L-iduronidase. It contains 6 N-linked oligosaccharide modification sites.",For the treatment of mucopolysaccharidosis,A16AB05,Alimentary Tract and Metabolism|Enzymes|Enzymes and Coenzymes|Glycoside Hydrolases|Hydrolases
DB00091,Cyclosporine,small molecule,"Cyclosporine is a calcineurin inhibitor known for its immunomodulatory properties that prevent organ transplant rejection and treat various inflammatory and autoimmune conditions. It is isolated from the fungus _Beauveria nivea_.[A174049] Initially manufactured by Sandoz and approved for use by the FDA in 1983, cyclosporine is now available in various products by Novartis (previously known as Sandoz).[L11097,L3734,L11118]","Cyclosporine is approved for a variety of conditions. Firstly, it is approved for the prophylaxis of organ rejection in allogeneic kidney, liver, and heart transplants. It is also used to prevent bone marrow transplant rejection. For the above indications, cyclosporine can be used in conjunction with azathioprine and corticosteroids. Finally, cyclosporine can be used in patients who have chronic transplant rejection and have received previous immunosuppressive therapy[L3002] and to prevent or tr",L04AD01|S01XA18,Agents causing hyperkalemia|Agents Causing Muscle Toxicity|Agents that produce hypertension|Agents that produce neuromuscular block (indirect)|Agents that reduce seizure threshold
DB00092,Alefacept,biotech,"Immunosuppressive dimeric fusion protein that consists of the extracellular CD2-binding portion of the human leukocyte function antigen-3 (LFA-3) linked to the Fc (hinge, CH2 and CH3 domains) portion of human IgG1. Produced by CHO cells, mW is 91.4 kD.","As an immunosuppressive drug, Alefacept can be used for treatment of moderate to severe chronic plaque psoriasis",L04AA15,"Amino Acids, Peptides, and Proteins|Antibodies|Antineoplastic and Immunomodulating Agents|Blood Proteins|Carbohydrates"
DB00093,Felypressin,biotech,"A synthetic nonapeptide comprising cysteinyl, phenylalanyl, phenylalanyl, glutaminyl, asparaginyl, cysteinyl, prolyl, lysyl, and glycinamide residues in sequence, with a disulfide bridge joining the two cysteine residues. Its antidiuretic effects are less than those of vasopressin. It is a non-catecholamine vasoconstrictor used in local anaesthetic injections for dental use, and is an ingredient of preparations that have been used for treatment of pain and inflammation of the mouth.","For use as an alternative to adrenaline as a localising agent, provided that local ischaemia is not essential.",,"Amino Acids, Peptides, and Proteins|Cardiovascular Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Nerve Tissue Proteins"
DB00094,Urofollitropin,biotech,"Urofollitropin is a urinary-derived follicle-stimulating hormone (FSH) that is extracted and purified from human urine samples. It consists of two non-covalently linked, non-identical glycoproteins designated as the alpha- and beta- subunits. The alpha- and beta- subunits have 92 and 111 amino acids. The alpha subunit is glycosylated at Asn 51 and Asn 78 while the beta subunit is glycosylated at Asn 7 and Asn 24. Urofollitropin is typically used injected subcutaneously in combination with human ",For treatment of female infertility,G03GA04,"Amino Acids, Peptides, and Proteins|Genito Urinary System and Sex Hormones|Gonadotropins|Gonadotropins and Antigonadotropins|Gonadotropins, Pituitary"
DB00095,Efalizumab,biotech,Humanized IgG1 kappa isotype monoclonal antibody that binds to human CD11a. Efalizumab has a molecular weight of approximately 150 kilodaltons and is produced in a Chinese hamster ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin. The FDA approved efalizumab in 2003. It was later withdrawn in 2009 due to a potential risk of progressive multifocal leukoencephalopathy (PML).[L43797],"For the treatment of adult patients with moderate to severe chronic plaque psoriasis, who are candidates for phototherapy or systemic therapy.",L04AG02,"Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antigens, CD11"
DB00097,Choriogonadotropin alfa,biotech,"Recombinant human chorionic gonadotropin with 2 subunits, alpha = 92 residues, beta = 145 residues, each with N-and O-linked carbohydrate moieties linked to ASN-52 and ASN-78 (on alpha subunit) and ASN-13, ASN-30, SER-121, SER-127, SER-132 and SER-138 (on beta subunit). The primary structure of the alpha-chain of r-hCG is identical to that of the alpha-chain of hCG, FSH and LH.",For the treatment of female infertility,G03GA08,Genito Urinary System and Sex Hormones|Gonadotropins|Gonadotropins and Antigonadotropins|Sex Hormones and Modulators of the Genital System
DB00098,Antithymocyte immunoglobulin (rabbit),biotech,Rabbit anti-thymocyte globulin. Thymoglobulin is a polyclonal antibody that suppresses certain types of immune cells responsible for acute organ rejection in transplant patients. Thymoglobulin is a mixture of antibodies intended to bind to various cell surface antigens. The most common mode of action of Thymoglobulin is via selective depletion of T-cells.,For prevention of renal transplant rejection,L04AA04,"Amino Acids, Peptides, and Proteins|Antibodies|Antibody-Surface Protein Interactions|Antineoplastic and Immunomodulating Agents|Biological Products"
DB00099,Filgrastim,biotech,"Filgrastim is a short-acting recombinant, non-pegylated human granulocyte colony-stimulating factor (G-CSF) analog produced by recombinant DNA technology. It has an amino acid sequence identical to endogenous G-CSF, but it is non-glycosylated unlike the endogenous G-CSF and has an N-terminal methionine added in the sequence for expression in _E. Coli_.[L40714] Human G-CSF is a glycoprotein that regulates the production and release of neutrophils from the bone marrow. Filgrastim mimics the biolog","Filgrastim is indicated to decrease the incidence of infection‚ as manifested by febrile neutropenia‚ in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a significant incidence of severe neutropenia with fever.[L40714]

Filgrastim is indicated for reducing the time to neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy treatment of patients with acute myeloid leukemia.[L40714]

Filgrastim is indic",L03AA02,"Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Biological Factors|Colony-Stimulating Factors|Glycoconjugates"
DB00100,Coagulation Factor IX (Recombinant),biotech,"Recombinant Coagulation Factor IX is a purified Factor IX glycoprotein produced by recombinant DNA technology. It has a primary amino acid sequence that is identical to the Ala148 allelic form of human factor IX, and has structural and functional characteristics similar to those of endogenous factor IX. It is not derived from human blood (unlike human Factor IX complex), and is instead produced by a genetically engineered Chinese hamster ovary (CHO) cell line that secretes recombinant Factor IX ",For treatment of hemophilia (Christmas disease).,,Blood Coagulation Factors|Hemostatics|Increased Coagulation Activity
DB00102,Becaplermin,biotech,"Becaplermin is produced by recombinant DNA technology by insertion of the gene for the B chain of platelet derived growth factor (PDGF) into the yeast, Saccharomyces cerevisiae. Becaplermin has a molecular weight of approximately 25 KD and is a homodimer composed of two identical polypeptide chains that are bound together by disulfide bonds.",For topical treatment of skin ulcers (from diabetes),D03AX06|A01AD08,"Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Angiogenesis Inducing Agents"
DB00103,Agalsidase beta,biotech,"Agalsidase beta is a recombinant human α-galactosidase A similar to [agalsidase alfa]. While patients generally do not experience a clinically significant difference in outcomes between the two drugs, some patients may experience greater benefit with agalsidase beta.[A220228,A220233] Use of agalsidase beta has decreased in Europe, in favor of agalsidase alfa, after a contamination event in 2009.[A220343]

Agalsidase beta was granted FDA approval on 24 April 2003.[L16383]",Agalsidase beta is indicated in the treatment of Fabry disease.[L16383],A16AB04,"Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Enzymes|Enzymes and Coenzymes|Galactosidases"
DB00104,Octreotide,biotech,"Acromegaly is a disorder caused by excess growth hormone (GH), increasing the growth of body tissues and causing metabolic dysfunction.[L14501] In most cases, it results from an anterior pituitary growth hormone-releasing tumor. Typically, the feet, hands, and face grow abnormally large; organomegaly and insulin resistance may also occur. Acromegaly is a life-threatening disease requiring life-long management.[L14501]

Octreotide is a long-acting drug with pharmacologic activities that mimic t","Octreotide by injection is used for the treatment of acromegaly and the reduction of flushing and diarrhea symptoms related to carcinoid tumors and/or vasoactive intestinal peptide (VIPoma) tumors.[L14513] The delayed-release oral formulation is used for the long-term treatment of acromegaly in patients who tolerate and respond adequately to injectable octreotide and [lanreotide].[L14507,L45528]",H01CB02,"Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Bradycardia-Causing Agents|Cytochrome P-450 CYP3A Inhibitors"
DB00105,Interferon alfa-2b,biotech,Interferon alpha 2b (human leukocyte clone hif-sn 206 protein moiety reduced). A type I interferon consisting of 165 amino acid residues with arginine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent.,"For the treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma.",L03AB05,"Adjuvants, Immunologic|Alfa Interferons|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antineoplastic Agents"
DB00106,Abarelix,small molecule,Synthetic decapeptide antagonist to gonadotropin releasing hormone (GnRH). It is marketed by Praecis Pharmaceuticals as Plenaxis. Praecis announced in June 2006 that it was voluntarily withdrawing the drug from the market.,For palliative treatment of advanced prostate cancer.,L02BX01,"Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Endocrine Therapy|Hormone Antagonists|Hormone Antagonists and Related Agents"
DB00107,Oxytocin,biotech,"Sir Henry H. Dale first identified oxytocin and its uterine contractile properties in 1906.[A229008,A228593,A229108] Like all other neurohypophysial hormones, oxytocin is composed of nine amino acids with a disulfide bridge between the Cys 1 and 6 residues.[A229008,A228593] In the mid-1950s, synthetic oxytocin was successfully synthesized by a biochemist named Vincent du Vigneaud; he was later recognized with a Nobel prize for his work.[A229108] Oxytocin continues to be an important tool in mode","Administration of exogenous oxytocin is indicated in the antepartum period to initiate or improve uterine contractions for vaginal delivery in situations where there is fetal or maternal concern.[L31433] For example, It may be used to induce labor in cases of Rh sensitization, maternal diabetes, preeclampsia at or near term, and when delivery is indicated due to prematurely ruptured membranes.[A229018,L31433] Importantly, oxytocin is not approved or indicated for elective induction of labor. Oxy",G02AC01|H01BB02,"Amino Acids, Peptides, and Proteins|Genito Urinary System and Sex Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Increased Uterine Smooth Muscle Contraction or Tone"
DB00108,Natalizumab,biotech,"Natalizumab is a recombinant humanized IgG4κ monoclonal antibody that binds to α4-integrin.[L48041] While natalizumab was originally approved by the FDA to treat multiple sclerosis in 2004, it was withdrawn from the market following multiple reports of fatal progressive multifocal leukoencephalopathy (PML). In 2006, the FDA reintroduced the drug to the market for multiple sclerosis.[A261326] Natalizumab was further approved by the FDA for the treatment of Crohn's Disease in January 2008.[A261331","Natalizumab is indicated as monotherapy for the treatment of relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults.[L48031, L48036, L49096] 

It is also indicated for inducing and maintaining clinical response and remission in adult patients with moderately to severely active Crohn’s disease with evidence of inflammation who have had an inadequate response to or are unable to tolerate, conv",L04AG03,"Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antineoplastic and Immunomodulating Agents"
DB00109,Enfuvirtide,biotech,"Enfuvirtide is a 36 amino acid biomimetic peptide that is structurally similar to the HIV proteins that are responsible for the fusion of the virus to cell membranes and subsequent intracellular uptake. The first agent in the novel class of antiretroviral drugs called HIV fusion inhibitors, enfuvirtide works by inhibiting HIV-1 fusion with CD4 cells.",Enfuvirtide is an antiretroviral drug used in combination therapy for the treatment of HIV-1/AIDS.,J05AX07,"Amino Acids, Peptides, and Proteins|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antigens"
DB00110,Palivizumab,biotech,"Humanized monoclonal antibody (IgG1k) produced by recombinant DNA technology, directed to an epitope in the A antigenic site of the F protein of respiratory syncytial virus (RSV). Synagis is a composite of human (95%) and murine (5%) antibody sequences. The human heavy chain sequence was derived from the constant domains of human IgG1 and the variable framework regions of the VH genes Cor (1) and Cess (2). The human lightchain sequence was derived from the constant domain of Ck and the variable ",For prophylaxis of respiratory diseases casued by respiratory syncytial virus.,J06BD01,"Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized"
DB00111,Daclizumab,biotech,"Humanized IgG1 Mab that binds to the human interleukin-2 receptor (anti-Tac or anti-CD25). Daclizumab is a composite of human (90%) and murine (10%) antibody sequences. The human sequences were derived from the constant domains of human IgG1 and the variable framework regions of the Eu myeloma antibody. The murine sequences were derived from the complementarity-determining regions of a murine anti-Tac antibody.

On 22 April 2008, Roche Registration Limited chose to voluntarily withdraw the mar",Zenapax is a humanized monoclonal antibody used for prevention of renal transplant rejection,L04AC01,"Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antineoplastic and Immunomodulating Agents"
DB00112,Bevacizumab,biotech,"There is a great deal of evidence indicating that vascular endothelial growth factor (VEGF) is important for the survival and proliferation of cancer cells.[A192939,A192837,A192891,A193275] VEGF plays an important role in angiogenesis, lymphangiogenesis, and tumor growth, which are all factors that contribute to its attractiveness as a therapeutic target for anti-cancer therapies.[A192834,A192888,A192837,A192891,A192894] 

In 2004, bevacizumab (Avastin) gained FDA approval for specific types o","As a vascular endothelial growth factor (VEGF) inhibitor, bevacizumab is used in several chemotherapy regimens to treat metastatic colorectal cancer; metastatic, unresectable, locally advanced or recurrent non-squamous non-small cell lung cancer; metastatic renal cell carcinoma; metastatic, persistent, or recurrent cervical cancer; primary peritoneal cancer; epithelial ovarian cancer; fallopian tube cancer; breast cancer; and recurrent glioblastoma.[L12648,L39233,L41514,L43130,L43302,L49826]

",L01FG01|S01LA08,"Amino Acids, Peptides, and Proteins|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antibodies|Antibodies, Monoclonal"
DB00113,Technetium Tc-99m arcitumomab,biotech,"Reduced Fab fragment of the murine IgG1 monoclonal antibody IMMU-4 (also called NP-4) with specificity for carcinoembryonic antigen (CEA) covalently labeled with Technitium 99. The molecule has a molecular weight of ~54,000 Daltons.",For imaging colorectal tumors,V09IA06,"Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Diagnostic Radiopharmaceuticals|Globulins"
DB00114,Pyridoxal phosphate,small molecule,"This is the active form of vitamin B6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (pyridoxamine).",For nutritional supplementation and for treating dietary shortage or imbalance.,A11HA06,Alimentary Tract and Metabolism|Coenzymes|Dietary Supplements|Enzymes and Coenzymes|Food
DB00115,Cyanocobalamin,small molecule,"Cyanocobalamin (commonly known as Vitamin B12) is a highly complex, essential vitamin, owing its name to the fact that it contains the mineral, cobalt. This vitamin is produced naturally by bacteria [A175276], and is necessary for DNA synthesis and cellular energy production. Vitamin B12 has many forms, including the cyano-, methyl-, deoxyadenosyl- and hydroxy-cobalamin forms. The _cyano_ form, is the most widely used form in supplements and prescription drugs [A175255], [FDA label].  Several ph","
**Nasal spray**

The cyanocobalamin nasal spray is indicated for the maintenance of vitamin B12 concentrations after normalization with intramuscular vitamin B12 therapy in patients with deficiency of this vitamin who have no nervous system involvement [FDA label].

Note:  CaloMist [FDA label], the nasal spray form, has not been evaluated for the treatment of newly diagnosed vitamin B12 deficiency.

**Injection forms (subcutaneous, intramuscular)**

These forms are indicated for vitami",B03BA01|B03AE01|B03BA51,"Antianemic Preparations|Blood and Blood Forming Organs|Corrinoids|Diet, Food, and Nutrition|Drugs that are Mainly Renally Excreted"
DB00116,Tetrahydrofolic acid,small molecule,"Tetrahydrofolic acid is a folic acid derivative that is produced from dihydrofolic acid after conversion by dihydrofolate reductase. It is converted into 5,10-methylenetetrahydrofolate by serine hydroxymethyltransferase. It is a soluble coenzyme in many reactions, especially in the metabolism of amino acids and nucleic acids.","For nutritional supplementation, also for treating dietary shortage or imbalance.",,"Coenzymes|Dietary Supplements|Enzymes and Coenzymes|Folic Acid and Derivatives|Heterocyclic Compounds, Fused-Ring"
